tiprankstipranks
pc:vivac

Vivace Therapeutics Inc

1510 Fashion Island Blvd Suite 310 San Mateo, California 94404, US
https://www.vivacetherapeutics.com/
Vivace Therapeutics Inc. is a biotechnology company focused on the discovery and development of small molecule cancer therapies. The company specializes in targeting the Hippo pathway, with its lead product, VT3989, being a first-in-class TEAD autopalmitoylation inhibitor. Vivace is advancing VT3989 towards a Phase 3 clinical trial, initially targeting mesothelioma, highlighting its commitment to innovative cancer treatment solutions.

Leadership & Board

Current Number of Employees12
Current LinkedIn Followers1,670

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$35M
Total Amount Raised$35M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$35M
Latest Funding Amount$35M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Employee Trend

Vivace Therapeutics Inc had 12 employees as of April 13, 2026. The number of employees increased by 0 (0.00%) week-over-week.
12Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Vivace Therapeutics Inc had 1,670 followers as of April 13, 2026. The number of followers increased by 6 (0.36%) week-over-week.
1,670Latest Followers Count
6(0.36%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 12, 2025
Series D
$35.00M

Investors

Investor Name
Funding Round

Related News and Analysis